|
|
|
 |
|
 |
 |
|||
Company News
|
Guava Technologies Completes $27 Million in Private Equity Financing
Proceeds to be used for commercialization of cell analysis systems and expansion of product portfolio.
Hayward, CA, 17 December 2003
top
Lorantis Receives £25 ($42) Million in new Financing Led by APAX Partners Funds
Investment will enable start of clinical trials on potentially revolutionary approaches to selectively treating immune diseases
Cambridge, UK, 17 November 2003
top
Labcyte Joins Forces with Picoliter
Sunnyvale, CA, and Union City, CA, 04 November 2003
top
Astex announces merger with metaGen Pharmaceuticals GmbH and improves cash position by £23m
Cambridge, UK, 31 October 2003
top
ParAllele Bioscience secures $22.5 million in financing
Funds to Support Commercialization of ParAllele’s Comprehensive Genetic Discovery Tools
South San Francisco, CA, 23 September 2003
top
Abingworth announces final closing of $350 million biotech fund
London, UK, 18 August 2003
Abingworth announces $350 million biotech fund
Fund more than two times oversubscribed
London, UK, 31 July 2003
top
Abingworth appoints leading UK biotech entrepreneurs
Allan Marchington and Raj Parekh join as Entrepreneurs in Residence
London, UK, 18 July 2003
top
Xenogen Raises $22 Million in Financing from Current and New Investors
Capital to be Used for the Continued Commercialization of Xenogen’s Unique Real-Time In Vivo Imaging Technology
Alameda, CA, 10 July 2003
top
Alnylam Pharmaceuticals And Ribopharma Merge To Create Biotechnology Leader In RNA Interference
- Company secures $24.6 million (EUR 21.5 million) in new financing and strengthens leadership in the RNA interference (RNAi) th
Cambridge, Mass., USA, and Kulmbach, Germany , 07 July 2003
top
Epigenomics raises € 21 (US$ 22.5) million in a third round of financing
Berlin, Germany, and Seattle, Washington, 03 April 2003
top
Ribopharma AG raises EUR 2 million in private financing round
Kulmbach, Germany, 27 January 2003
top
|
Archive:
|
|||||||||||||||||||||||||||||||||
2010